Medtronic MiniMed Recall
The US Food and Drug Administration (FDA) has issued a Class I Recall of Medtronic MiniMed™ 600 Series insulin pumps used for the management of diabetes. Class I recalls are the most serious type of recall issued by the FDA, indicating that the defective products may cause serious injuries or death.
If you or a love one experienced complications from Medtronic MiniMed, you may be entitled to compensation.
Which Devices are impacted by the recall?
The devices impacted by the recall are:
- Model 630G—Distributed from September 2016 to February 2020
- Model 670G—Distributed May 2015 to December 2020
463,464 devices have been recalled in the U.S. to date.
Defect can cause serious injury or death
Due to a missing or broken retainer ring, the device can deliver incorrect insulin doses, resulting in serious medical issues, including:
- Hypoglycemia
- Hyperglycemia
- Seizures
- Diabetic ketoacidosis
- Unconsciousness
- Death
The Recall
Medtronic informed customers about possible missing or broken clear retainer rings in the 630G and 670G pumps. The purpose of the retainer ring is to lock the insulin cartridge in place in the pump’s reservoir compartment. If the cartridge is not locked in place, too little or too much insulin can be delivered to the user.
Do you qualify for a Case?
If you or a loved one suffered an injury or death after using the MedTronic MiniMed insulin pump, you may be entitled to compensation.
